A comparative study of HLA genes in HLA-B27 positive ankylosing spondylitis and HLA-B27 positive peripheral reactive arthritis

Arthritis and Rheumatism

Volumn 39, Issue 6, 1996, Pages 943-949

  Westman, Pia ^a   Leirisalo Repo, Marjatta ^b   Partanen, Jukka ^a   Koskimies, Saija ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B27 ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC MARKER; HLA TYPING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; REACTIVE ARTHRITIS;

ADULT; ALLELES; ARTHRITIS, REACTIVE; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; HAPLOTYPES; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HLA-C ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING;

EID: 0029977423     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390611     Document Type: Article

References (53)

1. Khan MA, Kellner H: Immunogenetics of spondyloarthropathies. Rheum Dis Clin North Am 18:837-864, 1992
2. Ivanyi P: Immunogenetics of the spondyloarthropathies. Curr Opin Rheumatol 5:436-445, 1993
3. Kingsley G, Sieper J: Current perspectives in reactive arthritis. Immunol Today 14:387-391, 1993
4. Toivanen A, Toivanen P: Epidemiologic, clinical, and therapeutic aspects of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol 7:279-283. 1995
5. Erbinger A: Ankylosing spondylitis is caused by Klebsiella. Rheum Dis Clin North Am 18:105-121, 1992
6. Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki L-M, Suoranta H, Nissilä M, Hvidman L, Nielsen ED, Svejgaard A, Tiilikainen A. Laitinen O: Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 25:249-259, 1982
7. Good AE: Reiter's disease and ankylosing spondylitis. Acta Rheum Scand 11:305-317, 1965
8. Sairanen E, Paronen I, Mähönen H: Reiter's syndrome: a follow-up study. Acta Med Scand 185:57-63, 1969
9. Brewerton DA, Caffrey M, Hart FD, James DCO, Nicholls A, Sturrock RD: Ankylosing spondylitis and HL-A27. Lancet 1:904-907, 1973
10. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM: High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704-706, 1973
11. Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A: HL-A27 in reactive arthritis: a study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 17:521-526, 1974
12. Tiwari JL, Terasaki Pl: HLA and disease associations. New York, Springer Verlag, 1985
13. Kellner H, Yu D: The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27. Rheumatol Int 12:121-127, 1992
14. Lochead JA, Chalmers IA, Marshall WH, Larsen B, Skanes VM, Payne RH, Barnard JM: HLA-B27 haplotypes in family studies of ankylosing spondylitis. Arthritis Rheum 26:1011-1016, 1983
15. Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27:241-249, 1984
16. Hochberg MC, Bias WB, Arnett FC Jr: Family studies in HLA-B27 associated arthritis. Medicine (Baltimore) 57:463-475, 1978
17. Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB: Effect of natural polymorphism at residue 86 of the HLA-DRβ chain on peptide binding. J Immunol 147:1292-1298, 1991
18. Verreck FAW, Termijtelen A, Koning F: HLA-DRβ chain residue 86 controls DRαβ dimer stability. Eur J Immunol 23:1346-1350, 1993
19. Van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361-368, 1984
20. Westman P, Kuismin T, Partanen J, Koskimies S: An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet 20:103-109, 1993
21. Westman P, Partanen J, Leirisalo-Repo M, Koskimies S: Different DRB1*04 alleles predominate in the Finnish random population and in HLA-B27 positive subpopulations. Tissue Antigens 44: 329-331, 1994
22. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique, HLA 1991. Proceedings of the Eleventh International Histocompatihility Workshop and Conference. Edited by K Tsuji, M Aizawa, T Sasazuki. New York, Oxford University Press, 1992
23. Ota M, Seki T, Nomura N, Sugimura K, Mizuki N, Fukushima H, Tsuji K, Inoko H: Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 38:60-71, 1991
24. Tsuji K, Aizawa M, Sasazuki T, editors: HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. New York, Oxford University Press, 1992
25. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, Erlich HA, Klitz W: Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 148:249-258, 1992
26. Svejgaard A, Platz P, Ryder LP: HLA and disease 1982: a survey. Immunol Rev 70:193-218, 1983
27. Lokki M-L, Julin M: HLA-A, B, C gene and haplotype frequencies in the Finnish population. Tissue Antigens 20:239-250, 1982
28. Arnett KL, Parham P: HLA class I nucleotide sequences, 1995. Tissue Antigens 46:217-257, 1995
29. Parham P, Arnett KL, Adams EJ, Barber LD, Domena JD, Stewart D, Hildebrand WH, Little A-M: The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens 43:302-313, 1994
30. Robinson WP, van der Linden SF, Khan MA, Rentsch H-U, Cats A, Russell A, Thomson G: HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 32:1135-1141, 1989
31. Kwok WW, Thurtle P, Nepom GT: A genetically controlled anomaly between HLA-DQα and DQβ chains. J Immunol 143: 3598-3601, 1989
32. Kwok WW, Kovats S, Thurtle P, Nepom GT: HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J Immunol 150:2263-2272, 1993
33. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH, Gladman DD, Bonney GE, Rubenstein JD, Siminovitch KA: Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum 37:1212-1220, 1994
34. Lopez D, Barber DF, Villadungos JA, Lopez de Castro JA: Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2. J Immunol 150:2675-2686, 1993
35. Pfeifer JD, Wick MJ, Roberst RL, Findlay K, Normark SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362, 1993
36. Careless DJ, Inman RD: Etiopathogenesis of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol 7:290-298, 1995
37. Burney RO, Pile KD, Gibson K, Calin A, Kennedy LG, Sinnott PJ, Powis SH, Wordsworth BP: Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 53:58-60, 1994
38. Maksymowych WP, Wessler A, Schmitt-Egenolf M, Suarez-Almazor M, Ritzel G, von Birstel RC, Pazderka F, Russell AS: Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 21:665-669, 1994
39. Barron KS, Reveille JD, Carringlon M, Mann DL, Robinson MA: Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. Arthritis Rheum 38:684-689, 1995
40. Maksymowych WP, Tao S, Li Y, Wing M, Russell AS: Allelic variation at the TAP1 locus influences disease phenotype in HLA-B27 positive individuals with ankylosing spondylitis. Tissue Antigens 45:328-332, 1995
41. Westman P, Partanen J, Leirisalo-Repo M, Koskimies S: TAP1 and TAP2 polymorphism in HLA-B27 positive subpopulations: no allelic differences in ankylosing spondylitis and reactive arthritis. Hum Immunol 44:236-242, 1995
42. Buxton SE, Benjamin RJ, Clayberger C, Parham P, Krensky AM: Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27. J Exp Med 175:809-820, 1992
43. Khan MA, Kushner I, Braun WE: Genetic heterogeneity in primary ankylosing spondylitis. J Rheumatol 7:383-386, 1980
44. Khan MA: B7-creg and ankylosing spondylitis. Brit J Rheumatol 22:129-133, 1983
45. Thomson GTD, Minenko A, Schroeder M-L: Host risk factors for the development of reactive arthritis: a family study. J Rheumatol 20:1350-1352, 1993
46. Mielants H, Veys EM, Joos R, Noens L, Cuvelier C, de Vos M: HLA antigens in seronegative spondyloarthropathies: reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. J Rheumatol 14:466-471, 1987
47. Hermann E, Yu DTY, Meyer zum Büschenfelde K-H, Fleischer B: HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342:646-650, 1993
48. Altmann DM, Sansom D, Marsh SGE: What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 12:267-270, 1991
49. Calin A: HLA-B27: to type or not to type? Ann Intern Med 92:208-211, 1980
50. Khan MA: Clinical application of the HLA-B27 test in rheumatic diseases. Arch Intern Med 140:177-180, 1980
51. Hawkins BR, Dawkins RL, Christiansen FT, Zilko PJ: Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum 24:743-746, 1981
52. Arnett FC: Histocompatibility typing in the rheumatic diseases: diagnostic and prognostic implications. Rheum Dis Clin North Am 20:371-390, 1994
53. Leirisalo-Repo M, Suoranta H: Ten-year followup study of patients with Yersinia arthritis. Arthritis Rheum 31:533-537, 1988